Dmitry Balyasny’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Dmitry Balyasny’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,182	Closed	-$203K	–	3254
2023 Q4	$203K	Buy	+20,182	New	+$91.6K	﹤0.01%	2320
2022 Q4	–	Sell	-24,646	Closed	-$79K	–	3351
2022 Q3	$79K	Buy	+24,646	New	+$80.2K	﹤0.01%	2429

Dmitry Balyasny's GRCL Position: Q1 2024 in Review

Dmitry Balyasny sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 20,182 shares — an estimated $203K sold.

Dmitry Balyasny first reported a position in GRCL in Q3 2022 and held it in 2 quarters. The position peaked at $203K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

Dmitry Balyasny reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Dmitry Balyasny sold 20,182 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $203K.
Dmitry Balyasny first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q3 2022 and held it in 2 quarters.
Dmitry Balyasny's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $203K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.